Biblio
Export 129 results:
[ Author
Filters: First Letter Of Last Name is W [Clear All Filters]
“Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study.”, J Alzheimers Dis, vol. 65, no. 1, pp. 117-124, 2018.
, “Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1411-1427, 2017.
, “Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1249-1253, 2020.
, “Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1453-9, 2016.
, “The Effects of LW-AFC on Intestinal Microbiome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 907-19, 2016.
, “Association of COVID-19 with New-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 2, pp. 411-414, 2022.
, “Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 63, no. 2, pp. 835-845, 2018.
, “Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.”, J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
, “Can Diet Supplements of Macular Pigment of Lutein, Zeaxanthin, and Meso-zeaxanthin Affect Cognition?”, J Alzheimers Dis, vol. 87, no. 3, pp. 1079-1087, 2022.
, “Quantitative Proteomics Reveals the Mechanism of Oxygen Treatment on Lenses of Alzheimer's Disease Model Mice.”, J Alzheimers Dis, vol. 54, no. 1, pp. 275-86, 2016.
, “Helicobacter pylori Infection Is Associated with Long-Term Cognitive Decline in Older Adults: A Two-Year Follow-Up Study.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1351-1358, 2023.
, “Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank.”, J Alzheimers Dis, vol. 73, no. 2, pp. 609-618, 2020.
, “Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
, “Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.”, J Alzheimers Dis, vol. 51, no. 1, pp. 227-36, 2016.
, “The Down-Expression of ACE and IDE Exacerbates Exogenous Amyloid-β Neurotoxicity in CB2R-/- Mice.”, J Alzheimers Dis, vol. 64, no. 3, pp. 957-971, 2018.
, “Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1403-13, 2016.
, “Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1525-1539, 2017.
, “Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 81, no. 2, pp. 533-543, 2021.
, “Cortical Thickness and Microstructural White Matter Changes Detect Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 415-428, 2017.
, “Abnormal Functional Brain Networks in Mild Cognitive Impairment and Alzheimer's Disease: A Minimum Spanning Tree Analysis.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1093-1107, 2018.
, “Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares.”, J Alzheimers Dis, vol. 54, no. 1, pp. 359-71, 2016.
, “Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.”, J Alzheimers Dis, vol. 62, no. 2, pp. 855-865, 2018.
, “The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1.”, J Alzheimers Dis, vol. 64, no. 1, pp. 149-169, 2018.
, “Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 51, no. 1, pp. 45-55, 2016.
, “Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis.”, J Alzheimers Dis, vol. 87, no. 1, pp. 285-304, 2022.
,